Profile data is unavailable for this security.
About the company
Science in Sport plc is a United Kingdom-based performance nutrition company. The Company is engaged in the sports nutrition business that develops, manufactures, and markets nutrition products for professional athletes, sports and fitness enthusiasts and the active lifestyle community. The Company has two brands, PhD Nutrition, an active-nutrition brand targeting the active lifestyle community, and Science in Sport (SiS), an endurance nutrition brand among athletes and professional sports teams. Its PhD Nutrition brand comprises powders, bars, and supplements, including the high protein, low sugar range, PhD Smart. Its SiS brand includes gels, powders and bars focused on energy, hydration, and recovery. The two brands sell through its phd.com and scienceinsport.com digital platforms, third-party online sites, including Amazon and ebay, and retail distribution in the United Kingdom and internationally, including supermarkets, high street chains and specialist sports retailers.
- Revenue in GBP (TTM)65.93m
- Net income in GBP-7.07m
- Incorporated2013
- Employees158.00
- LocationScience in Sport PLC2Nd Floor 16-18 Hatton GardenFarringdonLONDON EC1N 8ATUnited KingdomGBR
- Phone+44 128 244 0980
- Fax+44 128 244 0981
- Websitehttp://www.scienceinsport.com/us/about
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Verici DX PLC | 793.70k | -6.84m | 18.86m | 14.00 | -- | 4.75 | -- | 23.76 | -0.0402 | -0.0402 | 0.0047 | 0.0164 | 0.0932 | -- | 1.59 | 56,692.55 | -80.32 | -- | -115.94 | -- | 1.58 | -- | -862.19 | -- | -- | -- | 0.0438 | -- | -- | -- | 23.43 | -- | -- | -- |
| Hemogenyx Pharmaceuticals PLC | 0.00 | -6.69m | 19.66m | 17.00 | -- | 6.11 | -- | -- | -0.0061 | -0.0061 | 0.00 | 0.0024 | 0.00 | -- | -- | 0.00 | -101.47 | -82.19 | -112.85 | -95.97 | -- | -- | -- | -- | -- | -28.03 | 0.5144 | -- | -- | -- | -68.14 | -- | 36.68 | -- |
| Skinbiotherapeutics PLC | 161.65k | -2.88m | 19.97m | 11.00 | -- | 5.15 | -- | 123.56 | -0.0165 | -0.0165 | 0.0009 | 0.0192 | 0.0522 | 0.8871 | 0.4181 | 14,695.45 | -93.07 | -52.07 | -115.26 | -57.33 | 62.90 | -- | -1,784.70 | -4,694.37 | 6.48 | -379.78 | 0.0259 | -- | 76.65 | -- | -1.52 | -- | 18.00 | -- |
| Incanthera PLC | 0.00 | -1.48m | 20.35m | 8.00 | -- | -- | -- | -- | -0.0192 | -0.0192 | 0.00 | -0.0086 | 0.00 | -- | -- | 0.00 | -373.20 | -101.74 | -- | -132.88 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -36.11 | -- | -- | -- |
| Oxford Biodynamics PLC | 510.00k | -10.83m | 27.10m | 45.00 | -- | 2.90 | -- | 53.14 | -0.0729 | -0.0729 | 0.0035 | 0.0299 | 0.0371 | 0.7987 | 0.332 | 11,333.33 | -78.82 | -39.72 | -105.32 | -45.52 | 52.16 | -- | -2,122.75 | -1,324.62 | 1.72 | -7.50 | 0.5154 | -- | 231.17 | -15.53 | -61.34 | -- | -1.60 | -- |
| CRUSHMETRIC Group Ltd | 390.84k | -862.90k | 30.17m | 20.00 | -- | 1.20 | -- | 77.18 | -0.007 | -0.007 | 0.0027 | 0.1042 | 0.0255 | 7.14 | 2.64 | 19,541.87 | -5.72 | -40.65 | -8.35 | -- | 34.66 | 37.39 | -224.56 | -140.54 | 0.072 | -14.42 | 0.0558 | -- | 119.19 | -1.40 | -7.26 | -- | 12.11 | -- |
| Science in Sport PLC | 65.93m | -7.07m | 34.63m | 158.00 | -- | 0.8701 | -- | 0.5253 | -0.0464 | -0.0464 | 0.4239 | 0.2184 | 0.8479 | 4.20 | 3.83 | 417,278.50 | -9.09 | -9.69 | -13.75 | -11.97 | 41.88 | 47.09 | -10.72 | -11.94 | 0.6921 | -2.31 | 0.2825 | -- | 1.97 | 32.50 | -96.47 | -- | 49.81 | -- |
| Sareum Holdings Plc | 0.00 | -4.26m | 46.42m | 5.00 | -- | 72.45 | -- | -- | -0.0614 | -0.0614 | 0.00 | 0.0059 | 0.00 | -- | -- | 0.00 | -160.20 | -71.41 | -195.05 | -81.48 | -- | -- | -- | -19,709.24 | -- | -6.61 | 0.00 | -- | -- | -- | -46.96 | -- | -- | -- |
| Arecor Therapeutics PLC | 4.57m | -8.55m | 48.70m | 50.00 | -- | 5.11 | -- | 10.65 | -0.2793 | -0.2793 | 0.1493 | 0.3111 | 0.2462 | -- | 1.33 | 91,460.00 | -46.06 | -- | -60.53 | -- | -- | -- | -187.05 | -- | 2.02 | -- | 0.0343 | -- | 90.30 | -- | 7.62 | -- | -- | -- |
| Venture Life Group PLC | 51.41m | 921.00k | 51.93m | 165.00 | 76.92 | 0.6802 | 6.42 | 1.01 | 0.0053 | 0.0053 | 0.3847 | 0.6028 | 0.42 | 2.80 | 3.15 | 311,575.80 | 0.7525 | 1.58 | 0.9274 | 1.83 | 39.19 | 40.14 | 1.79 | 3.99 | 0.7355 | 2.12 | 0.2424 | 0.00 | 16.89 | 22.33 | 77.12 | 31.30 | 18.85 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Lombard Odier Asset Management (Europe) Ltd.as of 03 Jan 2024 | 46.94m | 25.75% |
| Otus Capital Management Ltd.as of 16 Aug 2023 | 19.55m | 10.73% |
| J.O. Hambro Capital Management Ltd.as of 16 Aug 2023 | 15.30m | 8.39% |
| Aviva Investors Global Services Ltd.as of 13 May 2024 | 14.67m | 8.05% |
| Sarasin & Partners LLPas of 16 Aug 2023 | 11.13m | 6.11% |
| Schroder Investment Management Ltd.as of 12 Apr 2023 | 10.93m | 6.00% |
| River Global Investors LLPas of 16 Aug 2023 | 8.16m | 4.47% |
| Tellworth Investments LLPas of 14 Apr 2023 | 5.62m | 3.08% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2023 | 4.38m | 2.40% |
| Canaccord Genuity Wealth Ltd.as of 30 Sep 2022 | 2.40m | 1.32% |
